1. Kitahara CM, Schneider AB. Epidemiology of thyroid cancer. Cancer Epidemiol Biomarkers Prev. 2022; 31:1284–97.
2. Lee EK, Park YJ, Jung CK, Na DG. A narrative review of the 2023 Korean Thyroid Association management guideline for patients with thyroid nodules. Endocrinol Metab (Seoul). 2024; 39:61–72.
3. Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016; 26:1–133.
4. Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA. The 2023 Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2023; 33:1039–44.
5. Doubi A, Alrayes NS, Alqubaisi AK, Al-Dhahri SF. The value of repeating fine-needle aspiration for thyroid nodules. Ann Saudi Med. 2021; 41:36–42.
6. Suh CH, Baek JH, Choi YJ, et al. Efficacy and safety of core-needle biopsy in initially detected thyroid nodules via propensity score analysis. Sci Rep. 2017; 7:8242.
7. Kim HC, Kim YJ, Han HY, et al. First-line use of core needle biopsy for high-yield preliminary diagnosis of thyroid nodules. AJNR Am J Neuroradiol. 2017; 38:357–63.
8. Paja M, Del Cura JL, Zabala R, Korta I, Ugalde A, Lopez JI. Coreneedle biopsy in thyroid nodules: performance, accuracy, and complications. Eur Radiol. 2019; 29:4889–96.
9. Jung CK, Baek JH, Na DG, Oh YL, Yi KH, Kang HC. 2019 Practice guidelines for thyroid core needle biopsy: a report of the Clinical Practice Guidelines Development Committee of the Korean Thyroid Association. J Pathol Transl Med. 2020; 54:64–86.
10. Hahn SY, Shin JH, Oh YL, Park KW. Ultrasound-guided core needle biopsy techniques for intermediate or low suspicion thyroid nodules: which method is effective for diagnosis? Korean J Radiol. 2019; 20:1454–61.
11. Suh CH, Baek JH, Lee JH, et al. The role of core-needle biopsy in the diagnosis of thyroid malignancy in 4580 patients with 4746 thyroid nodules: a systematic review and meta-analysis. Endocrine. 2016; 54:315–28.
12. Padmanabhan V, Marshall CB, Akdas Barkan G, et al. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: a study of interobserver variability among cytopathologists. Diagn Cytopathol. 2017; 45:399–405.
13. Clary KM, Condel JL, Liu Y, Johnson DR, Grzybicki DM, Raab SS. Interobserver variability in the fine needle aspiration biopsy diagnosis of follicular lesions of the thyroid gland. Acta Cytol. 2005; 49:378–82.
14. Sripodok S, Benjakul N. Interobserver variability in inconclusive diagnostic categories of thyroid fine needle aspiration cytology: an urban-based tertiary hospital experience. Ann Diagn Pathol. 2023; 63:152083.
15. Jung CK. Reevaluating diagnostic categories and associated malignancy risks in thyroid core needle biopsy. J Pathol Transl Med. 2023; 57:208–16.
16. Elsheikh TM, Asa SL, Chan JK, et al. Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol. 2008; 130:736–44.
17. Seok JY, An J, Cho HY, Kim Y, Ha SY. Nuclear features of papillary thyroid carcinoma: comparison of core needle biopsy and thyroidectomy specimens. Ann Diagn Pathol. 2018; 32:35–40.
18. Haq F, Bychkov A, Jung CK. A matched-pair analysis of nuclear morphologic features between core needle biopsy and surgical specimen in thyroid tumors using a deep learning model. Endocr Pathol. 2022; 33:472–83.
19. Baloch ZW, Asa SL, Barletta JA, et al. Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol. 2022; 33:27–63.
20. Jung CK, Bychkov A, Kakudo K. Update from the 2022 World Health Organization classification of thyroid tumors: a standardized diagnostic approach. Endocrinol Metab (Seoul). 2022; 37:703–18.